Structural genomics of human proteins

Methods in Molecular Biology

Volumn 1140, Issue , 2014, Pages 27-34

  Osman, Khan Tanjid ^a   Edwards, Aled ^a  

^a NONE

Author keywords

Human membrane protein; Human proteins; Methyltransferases; Protein families; Protein kinases; Structural basis of disease

Indexed keywords

PROTEIN;

ARTICLE; CRYSTALLIZATION; GENE DUPLICATION; GENETIC VARIABILITY; HUMAN; HUMAN GENOME; NEXT GENERATION SEQUENCING; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FAMILY; SEQUENCE ALIGNMENT; STRUCTURAL GENOMICS; BIOLOGY; CHEMISTRY; GENETICS; GENOMICS; METHODOLOGY; MOLECULAR BIOLOGY; STRUCTURAL HOMOLOGY; X RAY CRYSTALLOGRAPHY;

COMPUTATIONAL BIOLOGY; CRYSTALLOGRAPHY, X-RAY; GENOME, HUMAN; GENOMICS; HUMANS; MOLECULAR BIOLOGY; PROTEINS; STRUCTURAL HOMOLOGY, PROTEIN;

EID: 84907924958     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4939-0354-2_2     Document Type: Article

References (38)

1. Edwards AM, Isserlin R, Bader GD, Frye SV, Willson TM, Yu FH (2010) Too many roads not taken. Nature 470:163–165
2. Arrowsmith CH, Bountra C, Fish PV, Lee K, Schapira M (2012) Epigenetic protein families: A new frontier for drug discovery. Nat Rev Drug Discov 11:384–400
3. Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S (2002) The protein kinase complement of the human genome. Science (New York, NY) 298:1912–1934
4. Stevens RC, Cherezov V, Katritch V, Abagyan R, Kuhn P, Rosen H, Wüthrich K (2013) The GPCR Network: A large-scale collaboration to determine human GPCR structure and function. Nat Rev Drug Discov 12:25–34
5. Hopkins AL, Groom CR (2002) The druggable genome. Nat Rev Drug Discov 1:727–730
6. Edwards A (2009) Large-scale structural biology of the human proteome. Annu Rev Biochem 78:541–568
7. Sadowski I, Stone JC, Pawson T (1986) A noncatalytic domain conserved among cytoplasmic protein-tyrosine kinases modifies the kinase function and transforming activity ofFujinami sarcoma virus P130gag-fps. Mol Cell Biol 6:4396–4408
8. Stone JC, Atkinson T, Smith M, Pawson T (1984) Identification of functional regions in the transforming protein of Fujinami sarcoma virus by in-phase insertion mutagenesis. Cell 37:549–558
9. Filippakopoulos P, Kofler M, Hantschel O, Gish GD, Grebien F, Salah E, Neudecker P, Kay LE, Turk BE, Superti-Furga G et al (2008) Structural coupling of SH2-kinase domains links Fes and Abl substrate recognition and kinase activation. Cell 134:793–803
10. Yu W, Chory EJ, Wernimont AK, Tempel W, Scopton A, Federation A, Marineau JJ, Qi J, Barsyte-Lovejoy D, Yi J et al (2012) Catalytic site remodelling of the DOT1L methyltransferase by selective inhibitors. Nat Commun 3:1288
11. Filippakopoulos P, Qi J, Picaud S, Shen Y, Smith WB, Fedorov O, Morse EM, Keates T, Hickman TT, Felletar I et al (2010) Selective inhibition of BET bromodomains. Nature 468:1067–1073
12. Fish PV, Filippakopoulos P, Bish G, Brennan PE, Bunnage ME, Cook AS, Federov O, Gerstenberger BS, Jones H, Knapp S et al (2012) Identification of a chemical probe for bromo and extra C-terminal bromodomain inhibition through optimization of a fragmentderived hit. J Med Chem 55:9831–9837
13. Guetg C, Lienemann P, Sirri V, Grummt I, Hernandez-Verdun D, Hottiger MO, Fussenegger M, Santoro R (2010) The NoRC complex mediates the heterochromatin formation and stability of silent rRNA genes and centromeric repeats. Embo J 29:2135–2146
14. Hewitson KS, Holmes SL, Ehrismann D, Hardy AP, Chowdhury R, Schofield CJ, McDonough MA (2008) Evidence that two enzyme-derived histidine ligands are sufficient for iron binding and catalysis by factor inhibiting HIF (FIH). J Biol Chem 283:25971–25978
15. James LI, Barsyte-Lovejoy D, Zhong N, Krichevsky L, Korboukh VK, Herold JM, MacNevin CJ, Norris JL, Sagum CA, Tempel W et al (2013) Discovery of a chemical probe for the L3MBTL3 methyllysine reader domain. Nat Chem Biol 9:184–191
16. Jones MH, Hamana N, Nezu J, Shimane M (2000) A novel family of bromodomain genes. Genomics 63:40–45
17. Kawamura A, Tumber A, Rose NR, King ON, Daniel M, Oppermann U, Heightman TD, Schofield C (2010) Development of homogeneous luminescence assays for histone demethylase catalysis and binding. Anal Biochem 404:86–93
18. King ON, Li XS, Sakurai M, Kawamura A, Rose NR, Ng SS, Quinn AM, Rai G, Mott BT, Beswick P et al (2010) Quantitative highthroughputscreening identifies 8- hydroxyquinolines as cell-active histone demethylase inhibitors. PLoS One 5:e15535
19. Kruidenier L, Chung CW, Cheng Z, Liddle J, Che K, Joberty G, Bantscheff M, Bountra C, Bridges A, Diallo H et al (2012) A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response. Nature 488:404–408
20. Picaud S, Da Costa D, Thanasopoulou A, Filippakopoulos P, Fish PV, Philpott M, Fedorov O, Brennan P, Bunnage ME, Owen DR et al (2013) PFI-1—A highly selective protein interaction inhibitor targeting BET bromodomains. Cancer Res 73(11):3336–3346
21. Rose NR, Woon EC, Kingham GL, King ON, Mecinovic J, Clifton IJ, Ng SS, Talib-Hardy J, Oppermann U, McDonough MA et al (2010) Selective inhibitors of the JMJD2 histone demethylases: combined nondenaturing mass spectrometric screening and crystallographic approaches. J Med Chem 53:1810–1818
22. Tian YM, Yeoh KK, Lee MK, Eriksson T, Kessler BM, Kramer HB, Edelmann MJ, Willam C, Pugh CW, Schofield CJ et al (2011) Differential sensitivity of hypoxia inducible factor hydroxylation sites to hypoxia and hydroxylase inhibitors. J Biol Chem 286:13041–13051
23. Vedadi M, Barsyte-Lovejoy D, Liu F, Rival- Gervier S, Allali-Hassani A, Labrie V, Wigle TJ, Dimaggio PA, Wasney GA, Siarheyeva A et al (2011) A chemical probe selectively inhibits G9a and GLP methyltransferase activity in cells. Nat Chem Biol 7:566–574
24. Orengo CA, Thornton JM (2005) Protein families and their evolution-a structural perspective. Annu Rev Biochem 74:867–900
25. Weigelt J, McBroom-Cerajewski LD, Schapira M, Zhao Y, Arrowsmith CH (2008) Structural genomics and drug discovery: All in the family. Curr Opin Chem Biol 12:32–39
26. Vedadi M, Niesen FH, Allali-Hassani A, Fedorov OY, Finerty PJ Jr, Wasney GA, Yeung R, Arrowsmith C, Ball LJ, Berglund H et al (2006) Chemical screening methods to identify ligands that promote protein stability, protein crystallization, and structure determination. Proc Natl Acad Sci U S A 103:15835–15840
27. Shyr D, Liu Q (2013) Next generation sequencing in cancer research and clinical application. Biol Proced Online 15:4
28. Hoischen A, Van Bon BW, Gilissen C, Arts P, Van Lier B, Steehouwer M, De Vries P, De Reuver R, Wieskamp N, Mortier G et al (2010) Denovo mutations of SETBP1 cause Schinzel-Giedion syndrome. Nat Genet 42:483–485
29. Janer A, Antonicka H, Lalonde E, Nishimura T, Sasarman F, Brown GK, Brown RM, Majewski J, Shoubridge EA (2012) An RMND1 Mutation causes encephalopathy associated with multiple oxidative phosphorylation complex deficiencies and a mitochondrial translation defect. Am J Hum Genet 91:737–743
30. Lo YM, Chan KC, Sun H, Chen EZ, Jiang P, Lun FM, Zheng YW, Leung TY, Lau TK, Cantor CR et al (2010) Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus. Sci Transl Med 2:61ra91
31. Ng SB, Buckingham KJ, Lee C, Bigham AW, Tabor HK, Dent KM, Huff CD, Shannon PT, Jabs EW, Nickerson DA et al (2010) Exome sequencing identifies the cause of a mendelian disorder. Nat Genet 42:30–35
32. Ng SB, Bigham AW, Buckingham KJ, Hannibal MC, McMillin MJ, Gildersleeve HI, Beck AE, Tabor HK, Cooper GM, Mefford HC et al (2010) Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome. Nat Genet 42:790–793
33. Saunders CJ, Miller NA, Soden SE, Dinwiddie DL, Noll A, Alnadi NA, Andraws N, Patterson ML, Krivohlavek LA, Fellis J et al (2012) Rapid whole-genome sequencing for genetic disease diagnosis in neonatal intensive care units. Sci Transl Med 4:154ra135
34. Veltman JA, Brunner HG (2012) De novo mutations in human genetic disease. Nat Rev Genet 13:565–575
35. Chaikuad A, Alfano I, Kerr G, Sanvitale CE, Boergermann JH, Triffitt JT, Von Delft F, Knapp S, Knaus P, Bullock AN (2012) Structure of the bone morphogenetic protein receptor ALK2 and implications for fibrodysplasia ossificans progressiva. J Biol Chem287:36990–36998
36. Roscioli T, Kamsteeg E-J, Buysse K, Maystadt I, Van Reeuwijk J, Van den Elzen C, Van Beusekom E, Riemersma M, Pfundt R, Vissers LELM et al (2012) Mutations in ISPD cause Walker- Warburg syndrome and defective glycosylation of α-dystroglycan. Nat enet 44:581–585
37. Savitsky P, Bray J, Cooper CD, Marsden BD, Mahajan P, Burgess-Brown NA, Gileadi O (2010) High-throughput production of human proteins for crystallization: The SGC experience. J Struct Biol 172:3–13
38. Graslund S, Sagemark J, Berglund H, Dahlgren LG, Flores A, Hammarstrom M, Johansson I, Kotenyova T, Nilsson M, Nordlund P et al (2008) The use of systematic N- and C-terminal deletions to promote production and structural studies of recombinant proteins. Protein Expr Purif 58:210–221